Skip to main content

Table 3 High-pressure liquid chromatography analysis of palmitoylethanolamide content in different commercially available palmitoylethanolamide products a

From: Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain

 

Normast 300 mg (tablet)

Normast 600 mg (tablet)

Normast 600 mg (microgranular)

PeaPure

PeaVera

Peanase

Sinerga

Supplier

Epitech Group

Epitech Group

Epitech Group

JP Russell

JP Russell

LJ Pharma

Galsor

Lot no.

D09813

D012A4

D067F3

12126A

14A09H

SK629

11283

PEA content/dose claimed

300 mg

600 mg

600 mg

400 mg

400 mg

300 mg

150 mg

PEA content found

300.8 mg

611.5 mg

614.5 mg

344.7 mg

347.8 mg

248.5 mg

71.4 mg

  1. aPEA-m, Micronized palmitoylethanolamide; PEA-um, Ultramicronized palmitoylethanolamide. Values exceeding 100% are due to the precision of the analytical methods used. Assay specification limits are 98% to 102%.